US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
WO2000018374A1
(en)
*
|
1998-10-01 |
2000-04-06 |
Elan Pharma International, Ltd. |
Controlled release nanoparticulate compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US7815937B2
(en)
*
|
1998-10-27 |
2010-10-19 |
Biovail Laboratories International Srl |
Quick dissolve compositions and tablets based thereon
|
AU1323400A
(en)
*
|
1998-10-27 |
2000-05-15 |
Fuisz Technologies Ltd. |
Microparticles containing peg and/or peg glyceryl esters
|
DK1126826T6
(en)
|
1998-11-02 |
2019-06-24 |
Alkermes Pharma Ireland Ltd |
Multiparticulate modified release of methylphenidate
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US20090104273A1
(en)
*
|
1999-06-22 |
2009-04-23 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
DE19931708A1
(de)
*
|
1999-07-08 |
2001-01-18 |
Bayer Ag |
Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen
|
UY26615A1
(es)
*
|
2000-03-16 |
2001-10-25 |
Pfizer Prod Inc |
Inhibidor de la glucogeno fosforilasa.
|
US7575761B2
(en)
*
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
US6656492B2
(en)
*
|
2000-06-30 |
2003-12-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Quick disintegrating tablet in buccal cavity and manufacturing method thereof
|
US20100010101A1
(en)
*
|
2000-07-05 |
2010-01-14 |
Capricorn Pharma, Inc. |
Rapid-Melt Compositions and Methods of Making Same
|
AU2001277230A1
(en)
*
|
2000-08-01 |
2002-02-13 |
Inhale Therapeutic Systems, Inc. |
Apparatus and process to produce particles having a narrow size distribution andparticles made thereby
|
CN1638739A
(zh)
*
|
2000-08-18 |
2005-07-13 |
法玛西雅厄普约翰美国公司 |
治疗成瘾性障碍的化合物
|
US20040043061A1
(en)
*
|
2000-09-15 |
2004-03-04 |
Leon Daniel S. |
Dissolvable films comprising suspended, non-soluble pharmaceutically active ingredients, apparatus and methods for their manufacture and use
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
US6982251B2
(en)
*
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US6559180B2
(en)
|
2001-03-27 |
2003-05-06 |
Yuri Busiashvili |
Nitroglycerin-menthol potentiation for treatment of angina
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
JP2005504266A
(ja)
*
|
2001-06-22 |
2005-02-10 |
エラン ファーマ インターナショナル,リミティド |
小規模ミルまたは微小流体工学を用いる高スループットスクリーニング法
|
ATE243028T1
(de)
*
|
2001-07-11 |
2003-07-15 |
Applied Pharma Res |
Fettlösliche substanzen enthaltende granulate und verfahren zu ihrer herstellung
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
DE60217367T2
(de)
*
|
2001-09-19 |
2007-10-18 |
Elan Pharma International Ltd. |
Nanopartikelzusammensetzungen enthaltend insulin
|
KR20040058189A
(ko)
*
|
2001-09-26 |
2004-07-03 |
파마시아 코포레이션 |
관능상 허용가능한 경구내 붕해 조성물
|
CA2461349C
(en)
|
2001-09-26 |
2011-11-29 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
US9358214B2
(en)
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
OA12666A
(en)
*
|
2001-10-10 |
2006-06-19 |
Pharmacia Corp Corporate Paten |
Intraorally disintegrating valdecoxib compositionsprepared by spray drying process.
|
JP2005508939A
(ja)
*
|
2001-10-12 |
2005-04-07 |
エラン ファーマ インターナショナル,リミティド |
即時放出および徐放特性を組み合わせて有する組成物
|
MY148466A
(en)
*
|
2001-10-26 |
2013-04-30 |
Merck Frosst Canada Ltd |
Granule formulation
|
CA2363528A1
(en)
*
|
2001-11-19 |
2003-05-19 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Immediate release tablet containing naproxen sodium
|
US20030129250A1
(en)
*
|
2001-11-20 |
2003-07-10 |
Advanced Inhalation Research Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
FR2834889B1
(fr)
*
|
2002-01-18 |
2004-04-02 |
Roquette Freres |
Forme pharmaceutique solide orodispersible
|
JP2005517690A
(ja)
*
|
2002-02-01 |
2005-06-16 |
ファイザー・プロダクツ・インク |
固体薬物分散物を含有する即時放出剤形
|
CA2475092C
(en)
|
2002-02-04 |
2012-05-01 |
Christian F. Wertz |
Nanoparticulate compositions having lysozyme as a surface stabilizer
|
AU2003209475A1
(en)
*
|
2002-03-07 |
2003-09-16 |
Vectura Limited |
Fast melt multiparticulate formulations for oral delivery
|
US20050191357A1
(en)
*
|
2002-03-20 |
2005-09-01 |
Yoshiaki Kawashima |
Method of manufacturing chemical-containing composite particles
|
US20030215502A1
(en)
*
|
2002-03-20 |
2003-11-20 |
Elan Pharma International Limited |
Fast dissolving dosage forms having reduced friability
|
CA2479665C
(en)
*
|
2002-03-20 |
2011-08-30 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
US9101540B2
(en)
*
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
ES2380318T3
(es)
|
2002-04-12 |
2012-05-10 |
Alkermes Pharma Ireland Limited |
Formulaciones nanoparticulares de megestrol
|
US7101576B2
(en)
*
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US6592852B1
(en)
*
|
2002-04-25 |
2003-07-15 |
Unilever Home & Personal Care Usa, Division Of Conopco, Inc. |
Zinc citrate beads in oral compositions
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
AU2003234452A1
(en)
*
|
2002-05-06 |
2003-11-11 |
Elan Pharma International Ltd. |
Nanoparticulate nystatin formulations
|
US20030215498A1
(en)
*
|
2002-05-17 |
2003-11-20 |
Harland Ronald S. |
Rapidly disintegrating comressed tablets comprising biologically active compounds
|
AU2003241477A1
(en)
*
|
2002-06-10 |
2003-12-22 |
Elan Pharma International, Ltd. |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
US20030228370A1
(en)
*
|
2002-06-11 |
2003-12-11 |
Michel Serpelloni |
Orodispersible solid pharmaceutical form
|
US20040258757A1
(en)
*
|
2002-07-16 |
2004-12-23 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
US7445796B2
(en)
*
|
2002-08-19 |
2008-11-04 |
L. Perrigo Company |
Pharmaceutically active particles of a monomodal particle size distribution and method
|
ATE487470T1
(de)
*
|
2002-09-11 |
2010-11-15 |
Elan Pharma Int Ltd |
Gel-stabilisierte wirkstoff-zusammensetzungen in nanoteilchengrösse
|
WO2004032980A1
(en)
*
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
US20060134195A1
(en)
*
|
2002-11-25 |
2006-06-22 |
Yourong Fu |
Mannose-based fast dissolving tablets
|
US20040173696A1
(en)
*
|
2002-12-17 |
2004-09-09 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
MXPA05007154A
(es)
|
2002-12-30 |
2005-09-21 |
Nektar Therapeutics |
Atomizador prepeliculizacion.
|
US8367111B2
(en)
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
CA2513064C
(en)
*
|
2003-01-31 |
2009-11-10 |
Elan Pharma International, Ltd. |
Nanoparticulate topiramate formulations
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
US8512727B2
(en)
*
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
JP5137228B2
(ja)
|
2003-03-07 |
2013-02-06 |
メルク・シャープ・アンド・ドーム・コーポレーション |
高コレステロール血症の処置のための置換アゼチジノン化合物、置換アゼチジノン処方物およびそれらの使用
|
DE602004018617D1
(de)
|
2003-03-07 |
2009-02-05 |
Schering Corp |
Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
|
EP1620075B1
(de)
*
|
2003-05-07 |
2020-06-24 |
Samyang Biopharmaceuticals Corporation |
Hochplastische granulate zur herstellung von schnell schmelzenden tabletten
|
US7354601B2
(en)
|
2003-05-08 |
2008-04-08 |
Walker Stephen E |
Particulate materials
|
JP2007501683A
(ja)
*
|
2003-05-22 |
2007-02-01 |
エラン ファーマ インターナショナル リミテッド |
γ線照射によるナノ粒子活性物質分散体の滅菌法
|
US20060226234A1
(en)
*
|
2003-06-11 |
2006-10-12 |
Kettinger Frederick R |
Pharmaceutical dosage forms having overt and covert markings for identification and authentification
|
FR2858556B1
(fr)
*
|
2003-08-06 |
2006-03-10 |
Galenix Innovations |
Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
|
ES2318330T3
(es)
*
|
2003-08-08 |
2009-05-01 |
Elan Pharma International Limited |
Nuevas composiciones de metaxalona.
|
US20050036977A1
(en)
*
|
2003-08-11 |
2005-02-17 |
Dilip Gole |
Taste-masked resinate and preparation thereof
|
US7390503B1
(en)
|
2003-08-22 |
2008-06-24 |
Barr Laboratories, Inc. |
Ondansetron orally disintegrating tablets
|
US20050053655A1
(en)
*
|
2003-09-05 |
2005-03-10 |
Pharmaceutical Industry Technology And Development Center |
Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same
|
CA2540040C
(en)
*
|
2003-10-07 |
2012-09-11 |
Andrx Pharmaceuticals Llc |
Rapidly disintegrating formulation
|
JP3841804B2
(ja)
|
2003-10-15 |
2006-11-08 |
富士化学工業株式会社 |
口腔内速崩壊性錠剤用の組成物
|
US8349361B2
(en)
|
2003-10-15 |
2013-01-08 |
Fuji Chemical Industry Co., Ltd. |
Composition for rapid disintegrating tablet in oral cavity
|
US20050196441A1
(en)
*
|
2003-11-05 |
2005-09-08 |
Dvorsky James E. |
Quick dissolving agrochemical and animal health products
|
ES2366646T3
(es)
*
|
2003-11-05 |
2011-10-24 |
Elan Pharma International Limited |
Composiciones en forma de nanopartículas que tienen un péptido como estabilizante superficial.
|
JP2007517015A
(ja)
*
|
2003-12-31 |
2007-06-28 |
ファイザー・プロダクツ・インク |
低溶解性薬物、ポロキサマーおよび安定化ポリマーの安定化された医薬用固体組成物
|
WO2005065657A2
(en)
*
|
2003-12-31 |
2005-07-21 |
Pfizer Products Inc. |
Solid compositions of low-solubility drugs and poloxamers
|
US7785619B2
(en)
*
|
2004-04-08 |
2010-08-31 |
Micro Nutrient, Llc |
Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
|
US7850987B2
(en)
*
|
2004-04-08 |
2010-12-14 |
Micronutrient, Llc |
Nutrient composition(s) and system(s) for individualized, responsive dosing regimens
|
WO2005097085A1
(en)
*
|
2004-04-08 |
2005-10-20 |
Micro Nutrient, Llc |
Nutrient system for individualized responsive dosing regimens
|
US20060013873A1
(en)
*
|
2004-07-16 |
2006-01-19 |
Chih-Chiang Yang |
Bioadhesive dosage form of steroids
|
US7956222B2
(en)
*
|
2004-08-17 |
2011-06-07 |
Eisai R&D Management Co., Ltd |
Methods for producing dibromofluorobenzene derivatives
|
US20140162965A1
(en)
|
2004-08-25 |
2014-06-12 |
Aegis Therapeutics, Inc. |
Compositions for oral drug administration
|
US20060046962A1
(en)
|
2004-08-25 |
2006-03-02 |
Aegis Therapeutics Llc |
Absorption enhancers for drug administration
|
US20090047347A1
(en)
*
|
2005-07-29 |
2009-02-19 |
Aegis Therapeutics, Inc. |
Compositions for Drug Administration
|
US9895444B2
(en)
|
2004-08-25 |
2018-02-20 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
US9114069B2
(en)
*
|
2004-08-25 |
2015-08-25 |
Aegis Therapeutics, Llc |
Antibacterial compositions for drug administration
|
US8747895B2
(en)
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
NZ589750A
(en)
|
2004-10-21 |
2012-07-27 |
Aptalis Pharmatech Inc |
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
|
EA200701065A1
(ru)
*
|
2004-11-16 |
2007-12-28 |
Элан Фарма Интернэшнл Лтд. |
Инъецируемые составы, содержащие нанодисперсный оланзапин
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
WO2006062875A1
(en)
*
|
2004-12-08 |
2006-06-15 |
Merck & Co., Inc. |
Ophthalmic nanoparticulate formulation of a cyclooxygenase-2 selective inhibitor
|
JP2008524239A
(ja)
*
|
2004-12-15 |
2008-07-10 |
エラン ファーマ インターナショナル リミティド |
ナノ粒子のタクロリムス製剤
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
AU2012201630B8
(en)
*
|
2004-12-31 |
2014-03-06 |
Iceutica Pty Ltd |
NanoParticle Composition(s) and Method for Synthesis Thereof
|
EP1835890A2
(de)
*
|
2005-01-06 |
2007-09-26 |
Elan Pharma International Limited |
Candesartan-nanopartikelformulierungen
|
AU2006214443C1
(en)
|
2005-02-15 |
2011-11-24 |
Alkermes Pharma Ireland Limited |
Aerosol and injectable formulations of nanoparticulate benzodiazepine
|
WO2006099121A2
(en)
*
|
2005-03-10 |
2006-09-21 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof
|
CA2601179A1
(en)
*
|
2005-03-16 |
2006-09-21 |
Elan Pharma International Limited |
Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
|
JP2008533173A
(ja)
*
|
2005-03-17 |
2008-08-21 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子ビスホスホネート組成物
|
KR20070121786A
(ko)
*
|
2005-03-23 |
2007-12-27 |
엘란 파마 인터내셔널 리미티드 |
나노입자형 코르티코스테로이드 및 항히스타민 제제
|
ES2390804T3
(es)
|
2005-04-08 |
2012-11-16 |
Ptc Therapeutics, Inc. |
Composiciones de un 1,2,4-oxadiazol oralmente activo para terapia de supresión de la mutación sin sentido
|
BRPI0607537A2
(pt)
*
|
2005-04-12 |
2009-09-15 |
Elan Pharma Int Ltd |
formulações de derivado de quinazolina nanoparticulado
|
CN101171000A
(zh)
*
|
2005-04-12 |
2008-04-30 |
依兰药物国际有限公司 |
包含环孢菌素的毫微粒和控制释放组合物
|
US20060246141A1
(en)
*
|
2005-04-12 |
2006-11-02 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
JP2009517485A
(ja)
|
2005-06-08 |
2009-04-30 |
エラン・ファルマ・インターナショナル・リミテッド |
セフジトレンを含むナノ粒子状および制御放出組成物
|
CA2617557A1
(en)
|
2005-08-04 |
2007-02-15 |
Sirtris Pharmaceuticals, Inc. |
Benzimidazole derivatives as sirtuin modulators
|
JP2009508859A
(ja)
|
2005-09-15 |
2009-03-05 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子アリピプラゾール製剤
|
KR20080070848A
(ko)
*
|
2005-11-03 |
2008-07-31 |
레드포인트 바이오 코포레이션 |
히드라존 유도체 및 이의 용도
|
US7811604B1
(en)
|
2005-11-14 |
2010-10-12 |
Barr Laboratories, Inc. |
Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
|
EA017290B1
(ru)
*
|
2005-11-28 |
2012-11-30 |
Домейн Раша Инвестментс Лимитед |
Композиции на основе ганаксолона
|
JP3884056B1
(ja)
*
|
2006-01-27 |
2007-02-21 |
秋山錠剤株式会社 |
口腔内速崩錠の製造方法
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
US20070243248A1
(en)
*
|
2006-04-14 |
2007-10-18 |
Cherukuri S Rao |
Rapidly disintegrating solid oral dosage form of liquid dispersions
|
US8226949B2
(en)
|
2006-06-23 |
2012-07-24 |
Aegis Therapeutics Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
AU2007265452A1
(en)
*
|
2006-06-26 |
2008-01-03 |
Mutual Pharmaceutical Company, Inc. |
Active agent formulations, methods of making, and methods of use
|
JP5508003B2
(ja)
*
|
2006-06-30 |
2014-05-28 |
アイスイティカ ピーティーワイ リミテッド |
ナノ粒子状の形態における生物学的に活性な化合物の調製のための方法
|
EP1891938A1
(de)
*
|
2006-07-24 |
2008-02-27 |
Cephalon France |
Mündlich auflösbare hohe Dosis von einer gefriergetrockneten Dosierungsform.
|
US20080031947A1
(en)
*
|
2006-07-24 |
2008-02-07 |
Cima Labs Inc. |
Orally dissolvable/disintegrable lyophilized dosage forms containing protected
|
BRPI0716053A2
(pt)
*
|
2006-08-22 |
2013-08-06 |
Redpoint Bio Corp |
compostos heterocÍclicos como promotores de adoÇantes
|
US8124598B2
(en)
|
2006-09-14 |
2012-02-28 |
Sharon Sageman |
7-keto DHEA for psychiatric use
|
WO2008033545A2
(en)
*
|
2006-09-15 |
2008-03-20 |
Redpoint Bio Corporation |
Triphenylphosphine oxide derivatives and uses thereof
|
US20080153845A1
(en)
*
|
2006-10-27 |
2008-06-26 |
Redpoint Bio Corporation |
Trpv1 antagonists and uses thereof
|
JP2010510988A
(ja)
*
|
2006-11-28 |
2010-04-08 |
マリナス ファーマシューティカルズ |
ナノ粒子製剤とその製造方法およびその利用
|
ES2531929T3
(es)
*
|
2006-12-20 |
2015-03-20 |
Teva Women's Health, Inc. |
Formas de dosificación solidas que se disgregan en la boca que comprenden progestina y métodos para hacer y usar las mismas
|
EP1935405A1
(de)
*
|
2006-12-22 |
2008-06-25 |
LEK Pharmaceuticals D.D. |
Im Mund zerfallende Tabletten
|
BRPI0808157A2
(pt)
*
|
2007-02-02 |
2014-07-01 |
Redpoint Bio Corp |
Uso de inibidor de trpm5 para regular insulina e a liberação de glp-1
|
JP3967767B1
(ja)
*
|
2007-02-08 |
2007-08-29 |
秋山錠剤株式会社 |
口腔内速崩錠の製造方法
|
KR20090129998A
(ko)
|
2007-02-11 |
2009-12-17 |
맵 파마슈티컬스, 인코포레이티드 |
부작용 프로파일을 최소화하면서 편두통의 빠른 완화를 가능하게 하는 dhe의 치료적 투여 방법
|
US20090004231A1
(en)
|
2007-06-30 |
2009-01-01 |
Popp Shane M |
Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
|
US8968709B2
(en)
|
2007-07-25 |
2015-03-03 |
3M Innovative Properties Company |
Therapeutic dental composition and related methods
|
US20100160274A1
(en)
*
|
2007-09-07 |
2010-06-24 |
Sharon Sageman |
7-KETO DHEA for Psychiatric Use
|
WO2009082478A1
(en)
|
2007-12-20 |
2009-07-02 |
Duramed Pharmaceuticals, Inc. |
Dosage regimens and pharmaceutical compositions and packages for emergency contraception
|
CA2756690C
(en)
|
2008-03-28 |
2016-08-16 |
Hale Biopharma Ventures, Llc |
Administration of benzodiazepine compositions
|
WO2009124357A1
(en)
*
|
2008-04-10 |
2009-10-15 |
Malvin Leonard Eutick |
Fast dissolving oral formulations for critical drugs
|
EP2293779A1
(de)
*
|
2008-04-24 |
2011-03-16 |
Evestra, Inc. |
Orale kontrazeptive dosierformen mit einem progestogen, das in einem enterischen polymer dispergiert ist, und ferner mit einem östrogen
|
TR201808694T4
(tr)
*
|
2008-06-20 |
2018-07-23 |
Merck Patent Gmbh |
Doğrudan sıkıştırılabilen ve hızlı parçalanan tablet matrisi.
|
DE102008047910A1
(de)
|
2008-09-19 |
2010-03-25 |
Molkerei Meggle Wasserburg Gmbh & Co. Kg |
Tablettierhilfsstoff auf Laktose- und Cellulosebasis
|
CA2750216A1
(en)
*
|
2008-12-15 |
2010-07-08 |
Fleming And Company, Pharmaceuticals |
Rapidly dissolving vitamin formulation and methods of using the same
|
US8440631B2
(en)
|
2008-12-22 |
2013-05-14 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
US20100159010A1
(en)
*
|
2008-12-24 |
2010-06-24 |
Mutual Pharmaceutical Company, Inc. |
Active Agent Formulations, Methods of Making, and Methods of Use
|
AU2010239081C1
(en)
|
2009-04-24 |
2014-11-06 |
Iceutica Pty Ltd |
A novel formulation of indomethacin
|
EP2253306A1
(de)
|
2009-05-18 |
2010-11-24 |
Royal College of Surgeons in Ireland |
Orodispersible Dosierungsformen mit Festarzneimitteldispersionen
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
AU2010254180B2
(en)
|
2009-05-27 |
2015-08-27 |
Alkermes Pharma Ireland Limited |
Reduction of flake-like aggregation in nanoparticulate active agent compositions
|
SG178376A1
(en)
|
2009-09-04 |
2012-03-29 |
Redpoint Bio Corp |
Sweetness enhancers including rebaudioside a or d
|
US9775819B2
(en)
*
|
2009-09-16 |
2017-10-03 |
R.P. Scherer Technologies, Llc |
Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
|
US20120230922A1
(en)
|
2009-09-22 |
2012-09-13 |
Redpoint Bio Corporation |
Novel Polymorphs of Rebaudioside C and Methods for Making and Using the Same
|
JP5309262B2
(ja)
|
2009-12-02 |
2013-10-09 |
アプタリス ファーマ リミテッド |
フェキソフェナジン・マイクロカプセル及びそれを含む組成物
|
WO2011146583A2
(en)
|
2010-05-19 |
2011-11-24 |
Elan Pharma International Limited |
Nanoparticulate cinacalcet formulations
|
MX2013002430A
(es)
|
2010-09-01 |
2013-07-22 |
Arena Pharm Inc |
Formas de dosis de disolucion de rápida de agonistas de 5-ht2c.
|
US10238684B2
(en)
|
2010-11-18 |
2019-03-26 |
Foundational Biosystems, Llc |
Micro- and nano-quantity sleep enhancing nutrient composition and method of enhancing central nervous system protein clearance using same
|
MX350838B
(es)
|
2011-02-11 |
2017-09-18 |
Grain Proc Corporation * |
Composicion de sal.
|
WO2012174158A2
(en)
|
2011-06-14 |
2012-12-20 |
Hale Biopharma Ventures, Llc |
Administration of benzodiazepine
|
CN103987840A
(zh)
|
2011-08-08 |
2014-08-13 |
国际香料香精公司 |
用于香草醛或香草醛β-D-葡萄糖苷的生物合成的组合物和方法
|
TWI526210B
(zh)
*
|
2012-02-15 |
2016-03-21 |
Taiho Pharmaceutical Co Ltd |
Oral pharmaceutical composition
|
JP5877778B2
(ja)
*
|
2012-05-28 |
2016-03-08 |
株式会社ホットアルバム炭酸泉タブレット |
錠剤の製造方法及び錠剤
|
AU2014226290B2
(en)
*
|
2013-03-04 |
2018-11-15 |
Vtv Therapeutics Llc |
Stable glucokinase activator compositions
|
JP6304896B2
(ja)
*
|
2013-07-30 |
2018-04-04 |
ライオン株式会社 |
錠剤
|
AU2014320088B2
(en)
|
2013-09-16 |
2017-06-01 |
Astrazeneca Ab |
Therapeutic polymeric nanoparticles and methods of making and using same
|
KR20160108828A
(ko)
|
2013-11-11 |
2016-09-20 |
임팩스 라보라토리즈, 인코포레이티드 |
신속하게 붕괴되는 제형 및 사용 방법
|
EP2880992A3
(de)
|
2013-12-05 |
2015-06-17 |
International Flavors & Fragrances Inc. |
Rebaudiosid C und dessen als Stereoisomere als Naturprodukt-Süßkraftverstärker
|
CN105007904A
(zh)
*
|
2014-02-07 |
2015-10-28 |
科学实验室药物公司 |
全天然无毒舌下药物递送系统
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|
US10722468B2
(en)
*
|
2014-08-14 |
2020-07-28 |
Brown University |
Compositions for stabilizing and delivering proteins
|
CN107249567B
(zh)
|
2014-11-21 |
2021-08-03 |
拜尔哈文制药股份有限公司 |
利鲁唑的舌下给药
|
US9925138B2
(en)
|
2015-01-20 |
2018-03-27 |
Handa Pharmaceuticals, Llc |
Stable solid fingolimod dosage forms
|
US20170042806A1
(en)
|
2015-04-29 |
2017-02-16 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
US10011629B2
(en)
|
2015-05-01 |
2018-07-03 |
Cocrystal Pharma, Inc. |
Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
|
US11173098B1
(en)
|
2016-02-05 |
2021-11-16 |
Gram Tactical Llc |
Magazines for tactical medicine dispensers
|
EP3458053B1
(de)
|
2016-05-20 |
2021-12-08 |
Biohaven Pharmaceutical Holding Company Ltd. |
Verwendung von riluzol, riluzolprodrugs oder riluzolanaloga mit immuntherapien zur behandlung von krebs
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
JP2019524816A
(ja)
|
2016-08-11 |
2019-09-05 |
オービッド・セラピューティクス・インコーポレイテッドOvid Therapeutics, Inc. |
てんかん性障害の処置のための方法および組成物
|
KR20240031326A
(ko)
|
2016-12-31 |
2024-03-07 |
바이오엑셀 테라퓨틱스 인코포레이티드 |
불안의 치료를 위한 설하 덱스메데토미딘의 용도
|
JP2019077644A
(ja)
*
|
2017-10-25 |
2019-05-23 |
富士フイルム株式会社 |
医薬組成物及び医薬組成物の製造方法
|
US20210023061A1
(en)
|
2017-11-12 |
2021-01-28 |
Biohaven Pharmaceutical Holding Company Ltd. |
Use of riluzole prodrugs to treat ataxias
|
EP3508199A1
(de)
*
|
2018-01-05 |
2019-07-10 |
Dompé farmaceutici S.p.A. |
Schnell freisetzende pharmazeutische zusammensetzungen mit ketoprofen-lysinsalz
|
CA3103431A1
(en)
|
2018-06-27 |
2020-01-02 |
Bioxcel Therapeutics, Inc. |
Film formulations containing dexmedetomidine and methods of producing them
|
CN109125775B
(zh)
*
|
2018-09-25 |
2021-02-09 |
广东爱车小屋电子商务科技有限公司 |
持久留香的空气清新剂及其制备方法
|
WO2020118142A1
(en)
|
2018-12-07 |
2020-06-11 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in prophylaxis and treatment of pospartum depression
|
CA3145388A1
(en)
|
2019-07-19 |
2021-01-28 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|
WO2021026124A1
(en)
|
2019-08-05 |
2021-02-11 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in treatment of status epilepticus
|
KR20220134529A
(ko)
|
2019-12-06 |
2022-10-05 |
마리누스 파마슈티컬스 인코포레이티드 |
복합 결절성 경화증의 치료에 사용하기 위한 가낙솔론
|
WO2021222739A1
(en)
|
2020-04-30 |
2021-11-04 |
Nanocopoeia, Llc |
Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib
|
KR20230012502A
(ko)
|
2020-05-18 |
2023-01-26 |
오렉쏘 에이비 |
약물 전달을 위한 신규한 약학 조성물
|
EP3928772A1
(de)
|
2020-06-26 |
2021-12-29 |
Algiax Pharmaceuticals GmbH |
Nanopartikuläre zusammensetzung
|
IT202000025885A1
(it)
*
|
2020-10-30 |
2022-04-30 |
Vacutest Kima S R L |
Composizione conservante per urine, dispositivo per il campionamento di urine e metodo per la produzione di un dispositivo per il campionamento di urine
|
US11672761B2
(en)
|
2020-11-16 |
2023-06-13 |
Orcosa Inc. |
Rapidly infusing platform and compositions for therapeutic treatment in humans
|
AR127780A1
(es)
|
2021-11-25 |
2024-02-28 |
Orexo Ab |
Nueva composición farmacéutica que comprende adrenalina
|